Benchmark Upgrades Nephros to Speculative Buy, Announces $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Robert Wasserman upgrades Nephros (NASDAQ:NEPH) from Hold to Speculative Buy and sets a $5 price target.
March 08, 2024 | 6:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nephros upgraded to Speculative Buy from Hold by Benchmark with a new price target of $5.
The upgrade from Hold to Speculative Buy by a reputable analyst, along with a specific price target, typically signals increased confidence in the company's future performance. This can lead to positive investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100